US Stock MarketDetailed Quotes

EWTX Edgewise Therapeutics

Watchlist

25.080
+0.070+0.28%

Close Feb 25 16:00 ET

25.080
0.0000.00%

Post 16:31 ET

2.37BMarket Cap-16.72P/E (TTM)

Edgewise Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Edgewise Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Nov 7, 2024	2024/Q3	0.000 / 0.000	--
Aug 8, 2024	2024/Q2	0.000 / 0.000	--
May 9, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Nov 7, 20242024/Q30.000 / 0.000--

Aug 8, 20242024/Q20.000 / 0.000--

May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Edgewise Therapeutics Earnings Reports

Edgewise Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 08:13 ET

Edgewise Therapeutics | 8-K: Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 7, 2024 08:03 ET

Edgewise Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 08:09 ET

Edgewise Therapeutics | 8-K: Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 8, 2024 08:04 ET